| # |
Authors |
Title |
Journal |
Month |
Year |
Link |
| 1 |
Agnorelli C, Garling HD, Paterson LM, Erritzoe D & Knudsen GM |
Recent advances in PET measures of brain 5-HT release |
Journal of Cerebral Blood Flow & Metabolism |
Mar |
2026 |
Link |
| 2 |
Agnorelli C, Peill J, Sawicka G, Kurtin D, Shatalina E, Ahmad K, Wall MB, Rua C, Godfrey K, Ertl N, Searle G, Zhou K, Osugo M, Weiss B, Greenway KT, Fagiolini A, Carhart-Harris R, Matthews PM, Rabiner EA, Nutt D & Erritzoe D |
Detecting neuroplastic effects induced by ketamine in healthy human subjects: A multimodal approach |
Journal of Cerebral Blood Flow & Metabolism |
Mar |
2026 |
Link |
| 3 |
Allen A, Young AH, Jellesma FC, Vorobev A, Ivanova E, Babakov N, Gisnarian A & Kannis-Dymand L |
An exploratory randomized controlled trial of an AI-enabled mental health intervention for generalized anxiety |
Journal of Affective Disorders, 401, 121275 |
— |
2026 |
Link |
| 4 |
Caulfield A, Moura R, Brugger S & Young AH et al. |
Mismatch negativity in patients with bipolar affective disorder: a systematic review and meta-analysis |
Journal of Psychopharmacology |
— |
2026 |
Link |
| 5 |
Chettuthara Moncy J, Xiao W, Woodham RD, Ghazi-Noori A-R, Rezaei H, Bramon E, Ritter P, Bauer M, Young AH, Fan Y & Fu CHY |
Deep learning based treatment remission prediction to transcranial direct current stimulation in bipolar depression using EEG power spectral density |
Psychiatry Research: Neuroimaging, 357, 112115 |
— |
2026 |
Link |
| 6 |
Fan Z, Searle G, Rizzo G, Albani J, Cella P, Comley R, Klein G, Passamonti L, Salinas C, Schwarz AJ, Iaccarino L, Tamagnan G, Eberling J, Marek K, Seibyl J & Gunn RN |
Toward harmonizing quantification of dopamine neuron imaging biomarkers in Parkinson’s disease: The Centamine Scale |
Annals of Neurology, 99(4), 949–963 |
Apr |
2026 |
Link |
| 7 |
Girn M, Doss MK, Roseman L, Preller KH, Palhano-Fontes F, Pasquini L, Barrett FS, Mallaroni P, Mason NL, Timmermann C, McCulloch DE, Fisher PM, Winston BS, Moujaes F, Muller F, Liechti ME, Vollenweider FX, Ramaekers JG, Kuypers K, Araujo DB, Sporns O, Siegel J, Dosenbach N, Nutt DJ, Carhart-Harris RL, Stamatakis EA & Bzdok D et al. |
An international mega-analysis of psychedelic drug effects on brain circuit function |
Nature Medicine, 32(4), 1543–1554 |
Apr |
2026 |
Link |
| 8 |
Goodwin GM, Aaronson ST, Alvarez O, Carhart-Harris R, Croal M, Feifel D, Hellerstein DJ, Husain MI, Kelly JR, Kirlic N, Licht RW, Marwood L, Nowakowska A, Páleníček T, Repantis D, Schoevers RA, Simmons H, Soares JC, Somers M, Tsai J, Wahba M, Williams E, Young AH, Young MB, Zisook S & Malievskaia E |
The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysis |
Journal of Affective Disorders, 406, 121662 |
— |
2026 |
Link |
| 9 |
Grant B, Kean J, de Silva NL, Aguilera R, Quinton OCB & Hughes A et al. |
Clinical features of androgen abuse withdrawal in men during the first year of cessation: a community dwelling study |
Journal of Clinical Endocrinology and Metabolism |
Mar |
2026 |
Link |
| 10 |
Hampsey E, Kalfas M, Carter L, Bloomfield M, Rezaei H, Young AH & Fu CHY |
A systematic review of transcranial electrical stimulation and meta-analysis of transcranial direct current stimulation RCTs in unipolar and bipolar depression |
Journal of Affective Disorders, 400, 121009 |
— |
2026 |
Link |
| 11 |
Hieronymus F, Huneke NTM, Månsson D, Rehn EM, Hagsäter M, Woodham RD, Soares JC, Young AH, Machado-Vieira R, Selvaraj S & Fu C |
Assessing the presence of biasing and non-biasing unblinding in a randomized controlled trial of a home-use tDCS device: An exploratory analysis |
Journal of Affective Disorders |
— |
2026 |
Link |
| 12 |
Jelen LA, O’Daly O, Zelaya FO, Stone JM, Young AH & Mehta MA |
Regional blood flow signatures of opioidergic modulation of ketamine in major depressive disorder: A randomized crossover study |
American Journal of Psychiatry |
— |
2026 |
Link |
| 13 |
Li L, Kodosaki E, Xu C et al. |
Systemic inflammation and its associations in acute moderate-severe Traumatic Brain Injury: a cross-sectional study |
Brain, Behavior, & Immunity – Health, 52 |
Mar |
2026 |
Link |
| 14 |
Lingford-Hughes A |
Addiction psychiatry: where we are and challenges in the UK |
International Review of Psychiatry, 38(1–3), 344–356 |
— |
2026 |
Link |
| 15 |
Lingford-Hughes A, Gronlund T & Gilvarry E |
Setting priorities for research in addiction |
The Lancet Psychiatry |
— |
2026 |
Link |
| 16 |
Matthews PM, Allen NE, Debette S, Doherty A, Douaud G, Duff EP, Elliott P, Fulda ES, Illina A, Le Grand Q, Lewandowski AJ, Mahoney R, Miller K, Rodriguez C, Rutter MK, Sandor C, Sims R, Smith SM & Wang C |
UK Biobank at 20 — a growing, global resource for dementia research |
Nature Reviews Neurology |
Apr |
2026 |
Link |
| 17 |
Melgosa-Ecenarro L, Radulescu CI, Doostdar N, Airey J, Chaloner FA, Zabouri N, Pedretti G, Osso F, Garrido Perez L, Pilch KS, Wang X, Mallach A, Sadeh S, Jackson J, Matthews PM & Barnes SJ |
Selective weakening of population-coupled synaptic activity in vivo in a mouse model of amyloid-beta pathology |
Nature Communications, 17(1), 3646 |
Mar |
2026 |
Link |
| 18 |
Mitchell J, McDonald SJ, Law M, Sharp D et al. |
Characterizing heterogeneity in brain morphology in traumatic brain injury using normative modeling |
Neurology, 106(8) |
Apr |
2026 |
Link |
| 19 |
Morrison PD, Murray RM, Jauhar S & Young AH |
The unique efficacy of clozapine is attributable to muscarinic receptor agonism |
Journal of Psychopharmacology |
— |
2026 |
Link |
| 20 |
Murray RM, Egerton A, Gao Y, Grace AA, Howes O, Jauhar S, Leucht S, Chen EYH, MacCabe JH, McCutcheon RA, Natesan S & Taylor D |
Why is clozapine uniquely effective in treatment-resistant schizophrenia? A review and proposal |
Biological Psychiatry, 99(7), 517–526 |
Apr |
2026 |
Link |
| 21 |
Nutt D |
Medicines for anxiety: A hundred years of tranquillity and more to come? |
Human Psychopharmacology: Clinical and Experimental, 41(2) |
Mar |
2026 |
Link |
| 22 |
Schalkamp A, Peall KJ, Harrison NA & Sandor C |
Comment on “Delayed Disease Onset Report in UK Biobank: Implications for Prodromal Studies in Parkinson’s Disease” |
Movement Disorders, 41(4), 1050–1052 |
Apr |
2026 |
Link |
| 23 |
Torso M, Tzaferou D, Valotti M, Hardwidge J, Hardingham I, Koychev I, Guo Q & Comley R et al. |
Diffusion magnetic resonance imaging of cortical microstructure differs in nonmanifest and manifest genetic Parkinson’s disease |
Movement Disorders |
Apr |
2026 |
Link |
| 24 |
Trompeter N, Nadarajah A, Sharpe H, Duffy F, Maloney E, Nicholls D, Serpell L, Schmidt U & Jewell T |
Views of people with disordered eating on current and alternative out-of-home calorie labelling policies in England: a mixed-methods survey |
BMJ Public Health, 4(2) |
Apr |
2026 |
Link |
| 25 |
Tsapekos D, Kalfas M, Strawbridge R, Swidzinski S, Burdick K & Young A |
Estimating cognitive impairment in bipolar disorder: should we account for premorbid IQ |
Acta Psychiatrica Scandinavica, 153(5), 468–476 |
May |
2026 |
Link |
| 26 |
Ulrichsen A, Mühlbauer E, Ludwig VM, Severus E, Cleare A, Jauhar S, Bauer M & Ebner-Priemer UW |
Sleep fluctuations precede self-reported mood changes in bipolar disorder: results from the BipoSense study |
International Journal of Bipolar Disorders, 14, 13 |
Mar |
2026 |
Link |
| 27 |
Wu LY, du Toit T, Georgiades T, Stafford EJ, Levine K, Fang Z-H, Jasaityte S, Martinez A-LG, Cullinane P, De Pablo Fernandez E, Blauwendraat C, Singleton AB, Scholz SW, Traynor BJ, Wood N, Hardy J, Chinnery P, Houlden H, Cain R, Troakes C, Chelban V, Serrano GE, Gveric D, McLean C, Love S, King A, Robinson AC, Roncaroli F, Shepherd C, Halliday G, Parkkinen L, Morris CM, Smith C, Beach TG, Gentleman S, Warner TT, Lashley T, Jaunmuktane Z, Real R & Morris HR |
Pathology and genetics in a global cohort of Parkinsonian Disorders |
openRxiv |
Mar |
2026 |
Link |
| 28 |
Yaqubi M, Thomas M, Talbot-Martin J et al. |
Characterising processing conditions that artifactually bias human brain tissue transcriptomes |
Nature Communications, 17, 2848 |
Apr |
2026 |
Link |
